Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Is Insulet's Stock Lagging Behind the Dow?
Insulet Corporation (PODD), known for its Omnipod insulin delivery system, has seen its stock decline significantly, falling 36% from its 52-week peak and underperforming the Dow Jones Industrial Average. Despite recent strong fourth-quarter results and surpassing Wall Street expectations, PODD’s stock has lagged behind both the Dow and competitor Medtronic plc. However, analysts maintain a “Strong Buy” rating with a substantial potential upside.